Back to results
US 2003/0158178 A1Published application
Heterocyclic retinoid compounds
AssigneeSyntex (U.S.A.) Inc.
InventorsMichael Klaus, Jean-Marc Lapierre
Life of this patent
Estimating the term…
Abstract
The current invention provide novel heterocyclic retinoid compounds, methods of treating or preventing chronic obstructive pulmonary disease, cancer and dermatological disorders, pharmaceutical compositions suitable for the treatment or prevention of these disorders and methods for delivering formulations of these retinoids to a mammal having these disorders.
Claims44
A compound according to structural formula (I):
- 57
- or a pharmaceutically acceptable salt, solvate or hydrate thereof wherein:
- n is an integer from 0 to 2;
- A is aryl or heteroaryl;
- Bis O, S or NR6;
- R is hydrogen or alkyl;
- Y is —OR7, —SR7 or —NR8R9;
- R7 is hydrogen, alkyl, aryl, arylalkyl, cycloalkyl or cycloalkyl-alkyl;
- R8 and R9 are independently hydrogen, alkyl, aryl, arylalkyl, cycloalkyl or cycloalkyl-alkyl or together with the nitrogen atom to which they are attached form a heterocycloamino ring;
- Z is —C(R101)2O—, —R102C═CR102—, —C≡C—, —C(R103)2S—, —C(O)O— or —C(O)NR10—;
- each of R10, R101, R102 and R103 is independently hydrogen or alkyl;
- R1 and R2 are independently hydrogen or alkyl;
- R3 is hydrogen or alkyl;
- and
- R4 and R5 are independently hydrogen, (C1-C8) alkyl or arylalkyl.
12 more elements
Dependencies are inferred from the claim text.